⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3609604 | 0.86 | FDPS (0.34) | — | |
| SCHEMBL3598303 | 0.79 | — | — | |
| SCHEMBL8629301 | 0.74 | — | — | |
| SCHEMBL8626670 | 0.72 | ALDH1A1 (0.31) | — | |
| SCHEMBL269675 | 0.72 | — | — | |
| SCHEMBL8625668 | 0.70 | — | — | |
| SCHEMBL5460994 | 0.66 | — | — | |
| SCHEMBL9846338 | 0.65 | — | — | |
| SCHEMBL3076818 | 0.65 | — | — | |
| SCHEMBL309833 | 0.65 | FDPS (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9051323-B2 | Substituted imidazopyrimidines and triazolopyrimidines | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-06-09 | — | — | US | claimed |
| US-20130040946-A1 | SUBSTITUTED IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-02-14 | — | — | US | claimed |
| US-8273752-B2 | Substituted imidazopyrimidines and triazolopyrimidines | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2012-09-25 | — | — | US | claimed |
| EP-2137188-B1 | SUBSTITUTED IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES | Bayer Pharma AG (DE) | 2012-06-06 | — | — | EP | claimed |
| US-20100113441-A1 | SUBSTITUTED IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-05-06 | — | — | US | claimed |
| EP-2137188-A2 | SUBSTITUTED IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-12-30 | — | — | EP | claimed |
| WO-2008113469-A2 | SUBSTITUTED IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-09-25 | — | — | WO | claimed |
| US-9051323-B2 | Substituted imidazopyrimidines and triazolopyrimidines | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-06-09 | — | — | US | disclosed |
| US-20130040946-A1 | SUBSTITUTED IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-02-14 | — | — | US | disclosed |
| US-8273752-B2 | Substituted imidazopyrimidines and triazolopyrimidines | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2012-09-25 | — | — | US | disclosed |
| EP-2137188-B1 | SUBSTITUTED IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES | Bayer Pharma AG (DE) | 2012-06-06 | — | — | EP | disclosed |
| US-20100113441-A1 | SUBSTITUTED IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-05-06 | — | — | US | disclosed |
| EP-2137188-A2 | SUBSTITUTED IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-12-30 | — | — | EP | disclosed |
| EP-1263478-A2 | FUNCTIONAL RADIOGRAPHIC IMAGING METHODS AND AGENTS | Veritas Pharmaceuticals (US) | 2002-12-11 | — | — | EP | disclosed |
| US-20020039401-A1 | Radiographic assessment of tissue after exposure to a compound | VERITAS PHARMACEUTICALS, INC. | 2002-04-04 | — | — | US | disclosed |
| US-20010038682-A1 | Radiographic assessment of tissue response to compounds | VERITAS PHARMACEUTICALS INC., A DELAWARE CORP. | 2001-11-08 | — | — | US | disclosed |
| US-20010031035-A1 | Functional radiographic imaging methods and agents | VERITAS PHARMACEUTICALS INC. | 2001-10-18 | — | — | US | disclosed |
| WO-2001068151-A2 | FUNCTIONAL RADIOGRAPHIC IMAGING METHODS AND AGENTS | VERITAS PHARMACEUTICALS (US) | 2001-09-20 | — | — | WO | disclosed |
| WO-2001067958-A2 | RADIOGRAPHIC ASSESSMENT OF TISSUE RESPONSE TO COMPOUNDS | VERITAS PHARMACEUTICALS (US) | 2001-09-20 | — | — | WO | disclosed |
| WO-2001067959-A2 | RADIOGRAPHIC ASSESSMENT OF TISSUE RESPONSE TO COMPOUNDS | VERITAS PHARMACEUTICALS (US) | 2001-09-20 | — | — | WO | disclosed |